These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31186172)

  • 21. Re: Dan Wood, Andrew Baird, Luca Carmignani, et al. Lifelong Congenital Urology: The Challenges for Patients and Surgeons. Eur Urol 2019;75:1001-7.
    Cheng C; Ma S; Liu Y
    Eur Urol; 2019 Oct; 76(4):e93. PubMed ID: 31331781
    [No Abstract]   [Full Text] [Related]  

  • 22. Re: Andrew Vickers, Sigrid V. Carlsson, Matthew Cooperberg. Routine Use of Magnetic Resonance Imaging for Early Detection of Prostate Cancer Is Not Justified by the Clinical Trial Evidence. Eur Urol 2020;78:304-6.
    Sun Y; Sun F; Wei Q; Huang J; Duan R
    Eur Urol; 2021 Jan; 79(1):e14-e15. PubMed ID: 33121827
    [No Abstract]   [Full Text] [Related]  

  • 23. Re: Tobias Nordström, Andrew Vickers, Melissa Assel, Hans Lilja, Henrik Grönberg, Martin Eklund. Comparison Between the Four-kallikrein Panel and Prostate Health Index for Predicting Prostate Cancer. Eur Urol 2015;68:139-46.
    Vickers A; Nordström T; Assel M; Lilja H; Grönberg H; Eklund M
    Eur Urol; 2018 Aug; 74(2):e35-e36. PubMed ID: 29731258
    [No Abstract]   [Full Text] [Related]  

  • 24. Re: Andrew J. Vickers. Effects of Magnetic Resonance Imaging Targeting on Overdiagnosis and Overtreatment of Prostate Cancer. Eur Urol 2021;80:567-72.
    Montorsi F; Gandaglia G; Briganti A
    Eur Urol; 2021 Dec; 80(6):e147-e148. PubMed ID: 34598832
    [No Abstract]   [Full Text] [Related]  

  • 25. Re: William C. Jackson, Matthew J. Schipper, Skyler B. Johnson, et al. Duration of Androgen Deprivation Therapy Influences Outcomes for Patients Receiving Radiation Therapy Following Radical Prostatectomy. Eur Urol 2016;69:50-7. Re: Ronald C. Chen. Postprostatectomy Radiotherapy: Whether and How Long to Give Concurrent Androgen Deprivation Therapy. Eur Urol 2016;69:58-9: Which patients need treatment intensification?
    Dal Pra A; Spahn M
    Eur Urol; 2016 Apr; 69(4):e74-e75. PubMed ID: 26508311
    [No Abstract]   [Full Text] [Related]  

  • 26. Re: Veeru Kasivisvanathan, Armando Stabile, Joana B. Neves, et al. Magnetic Resonance Imaging-targeted Biopsy Versus Systematic Biopsy in the Detection of Prostate Cancer: A Systematic Review And Meta-analysis. Eur Urol 2019;76:284-303.
    Montorsi F; Gandaglia G; Briganti A
    Eur Urol; 2019 Nov; 76(5):e132. PubMed ID: 31400947
    [No Abstract]   [Full Text] [Related]  

  • 27. Re: Andrew Vickers, Sigrid V. Carlsson, Matthew Cooperberg. Routine Use of Magnetic Resonance Imaging for Early Detection of Prostate Cancer Is Not Justified by the Clinical Trial Evidence. Eur Urol 2020;78:304-6: Prebiopsy MRI: Through the Looking Glass.
    van den Bergh RCN; Rouvière O; van der Kwast T;
    Eur Urol; 2020 Sep; 78(3):310-313. PubMed ID: 32660749
    [No Abstract]   [Full Text] [Related]  

  • 28. Re: Riccardo Autorino, Homayoun Zagar, Mirandolino B. Mariano, et al. Perioperative Outcomes of Robotic and Laparoscopic Simple Prostatectomy: A European-American Multi-institutional Analysis. Eur Urol 2015;68:86-94Re: Matthew Bultitude, Ben Challacombe. Simple Prostatectomy: A Step Too Far for Laparoscopy? Eur Urol 2015;68:95-6.
    Montorsi F; Gandaglia G
    Eur Urol; 2015 Jul; 68(1):e7-8. PubMed ID: 25660079
    [No Abstract]   [Full Text] [Related]  

  • 29. Re: Rita Faria, Marta O. Soares, Eldon Spackman, et al. Optimising the Diagnosis of Prostate Cancer in the Era of Multiparametric Magnetic Resonance Imaging: A Cost-effectiveness Analysis Based on the Prostate MR Imaging Study (PROMIS). Eur Urol 2018;73:23-30.
    Martini A; Gupta A; Cumarasamy S; Tewari AK
    Eur Urol; 2018 Apr; 73(4):e108-e109. PubMed ID: 29132712
    [No Abstract]   [Full Text] [Related]  

  • 30. Re: Christoper J. Logothetis, Andrew W. Hahn. Challenging the Prevailing Therapeutic Dogma for Prostate Cancer: The Case for an Overlap Syndrome. Eur Urol 2024;85:3-7.
    Wassersug RJ; Schellhammer PF; Wibowo E
    Eur Urol; 2024 Jun; 85(6):e173-e174. PubMed ID: 38538424
    [No Abstract]   [Full Text] [Related]  

  • 31. Re: Philip Cornford, Roderick C.N. van den Bergh, Erik Briers, et al. EAU-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II-2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer. Eur Urol 2021;79:263-82.
    von Eyben FE
    Eur Urol; 2021 Jun; 79(6):e176. PubMed ID: 33712301
    [No Abstract]   [Full Text] [Related]  

  • 32. Re: Ian A. Donaldson, Roberto Alonzi, Dean Barratt, et al. Focal Therapy: Patients, Interventions, and Outcomes-A Report from a Consensus Meeting. Eur Urol 2015;67:771-7.
    Kamrava M
    Eur Urol; 2015 Jul; 68(1):e14. PubMed ID: 25703574
    [No Abstract]   [Full Text] [Related]  

  • 33. Re: Henrik Grönberg, Martin Eklund, Wolfgang Picker, et al. Prostate Cancer Diagnostics Using a Combination of the Stockholm3 Blood Test and Multiparametric Magnetic Resonance Imaging. Eur Urol 2018;74:722-8.
    Rud E; Lauritzen P; Baco E
    Eur Urol; 2019 Apr; 75(4):e103. PubMed ID: 30528223
    [No Abstract]   [Full Text] [Related]  

  • 34. Re: Yaw A. Nyame, Matthew R. Cooperberg, Marcus G. Cumberbatch, et al. Deconstructing, Addressing, and Eliminating Racial and Ethnic Inequities in Prostate Cancer Care. Eur Urol 2022;82:341-51.
    Sirufo MM; Ginaldi L; De Martinis M
    Eur Urol; 2023 Apr; 83(4):e102. PubMed ID: 36670032
    [No Abstract]   [Full Text] [Related]  

  • 35. Re: Won Sik Ham, Heather J. Chalfin, Zhaoyong Feng, et al. New Prostate Cancer Grading System Predicts Long-term Survival Following Surgery for Gleason Score 8-10 Prostate Cancer. Eur Urol 2017;71:907-12.
    Fankhauser CD; Mucci LA; Gerke TA
    Eur Urol; 2017 Jul; 72(1):e9-e10. PubMed ID: 28108146
    [No Abstract]   [Full Text] [Related]  

  • 36. Re: Jacob A. Burns, Adam B. Weiner, William J. Catalone, et al. Inflammatory Bowel Disease and the Risk of Prostate Cancer. Eur Urol 2019;75:846-52.
    Gul ZG; Martini A; Olsson CA
    Eur Urol; 2019 Oct; 76(4):e98. PubMed ID: 31160097
    [No Abstract]   [Full Text] [Related]  

  • 37. Re: Christopher E. Bayne, Stephen B. Williams, Matthew R. Cooperberg, et al. Treatment of the Primary Tumor in Metastatic Prostate Cancer: Current Concepts and Future Perspectives. Eur Urol 2016;69:775-87.
    Yang L; Qiu S; Wei Q
    Eur Urol; 2017 Feb; 71(2):e49-e50. PubMed ID: 27451134
    [No Abstract]   [Full Text] [Related]  

  • 38. Re: Brandon A. Mahal, David D. Yang, Natalie Q. Wang, et al. Clinical and Genomic Characterization of Low-Prostate-specific Antigen, High-grade Prostate Cancer. Eur Urol 2018;74:146-54.
    Leppert JT; Brooks JD
    Eur Urol; 2018 Nov; 74(5):e110-e111. PubMed ID: 30017399
    [No Abstract]   [Full Text] [Related]  

  • 39. Re: Jan P. Radtke, Constantin Schwab, Maya B. Wolf, et al. Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.12.052.
    Williams SB; Ward JF
    Eur Urol; 2016 Sep; 70(3):e77-8. PubMed ID: 26988610
    [No Abstract]   [Full Text] [Related]  

  • 40. Re: George J. Netto, Mahul B. Amin, Daniel M. Berney, et al. The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs-Part B: Prostate and Urinary Tract Tumors. Eur Urol. 2022:82:469-82.
    Wei Y; Huang H; Ye L
    Eur Urol; 2023 Jan; 83(1):e15. PubMed ID: 36208966
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.